Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study.
about
Metabolic syndrome in children with chronic kidney disease and after renal transplantationDiabetic Nephropathy: New Risk Factors and Improvements in DiagnosisThe effects of vitamin D supplementation on hepatic dysfunction, vitamin D status, and glycemic control in children and adolescents with vitamin D deficiency and either type 1 or type 2 diabetes mellitusApolipoprotein-defined lipoproteins and apolipoproteins: associations with abnormal albuminuria in type 1 diabetes in the diabetes control and complications trial/epidemiology of diabetes interventions and complications cohortNormoglycemic diabetic nephropathy: the role of insulin resistance.A new modified CKD-EPI equation for Chinese patients with type 2 diabetes.Prevalence and control of hypertension and albuminuria in South Korea: focus on obesity and abdominal obesity in the Korean National Health and Nutrition Examination Survey, 2011-2012.Central obesity and albuminuria: both cross-sectional and longitudinal studies in Chinese.U-shaped association between central body fat and the urinary albumin-to-creatinine ratio and microalbuminuriaLong-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort.Association of subcutaneous and visceral adiposity with albuminuria: the Framingham Heart Study.Adiposity patterns and the risk for ESRD in postmenopausal womenLongitudinal association between serum leptin concentration and glomerular filtration rate in humansMetabolic acidosis-induced insulin resistance and cardiovascular riskObesity, metabolic syndrome and diabetic nephropathyProgression to microalbuminuria in patients with type 1 diabetes: a seven-year prospective study.Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes.Lifestyle factors and indices of kidney function in the Framingham Heart StudyAbdominal Obesity, Race and Chronic Kidney Disease in Young Adults: Results from NHANES 1999-2010.The Combined Influence of Psychological Factors on Biomarkers of Renal Functioning in African Americans.An Investigation into the Antiobesity Effects of Morinda citrifolia L. Leaf Extract in High Fat Diet Induced Obese Rats Using a (1)H NMR Metabolomics ApproachImpact of Lifestyle Modification on Diabetic Kidney DiseaseObesity and diabetic kidney disease.The dose-response effect of insulin sensitivity on albuminuria in children according to diabetes typeDoes renin angiotensin system blockade deserve preferred status over other anti-hypertensive medications for the treatment of people with diabetes?Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic controlRenal function following three distinct weight loss dietary strategies during 2 years of a randomized controlled trialTemporal trends in the prevalence of diabetic kidney disease in the United StatesIntra-abdominal fat and elevated urine albumin excretion in men with type 1 diabetes.Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus.Abdominal obesity is associated with microalbuminuria and an elevated cardiovascular risk profile in patients with hypertension.Kidney disease and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study.Early nephropathy in type 1 diabetes: the importance of early renal function decline.Obesity and change in estimated GFR among older adults.Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study.Cigarette smoking and chronic kidney diseases.Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease.Soluble epoxide hydrolase in podocytes is a significant contributor to renal function under hyperglycemia.Abdominal adiposity contributes to adverse glycemic control and albuminuria in Chinese type 2 diabetic patients: A cross-sectional study.Increased body mass index is a risk factor for end-stage renal disease in the Chinese Singapore population.
P2860
Q27027049-8D3E4BA7-BB08-46FE-BB6D-BD5F6D35DBBFQ33583018-A60FA339-3A16-4D27-BE58-AAFCDC1C1885Q33740329-BF94EB49-F9F1-499C-8268-CEF90FABBD3FQ33781706-70C6F593-208B-4D6E-9AE1-93F50C3816E1Q33935871-6921DE4C-5D87-426A-A51C-A3855AC9EAEDQ34338321-07A03675-6F87-457D-8339-E9A9DE48BE93Q34434615-45D0DF4D-1C80-43FD-B0F2-AB3A16D350F4Q34515571-256010AC-1A48-457F-8941-AB7FBC93B41EQ34675457-97B5BF03-60F9-4070-8527-8781AB891273Q34891831-96DBDF07-39C3-4C92-8CFC-331AC8F3725DQ34988107-72D86A74-6436-4B68-8F73-847D994979D1Q35051169-52E713D0-BBE9-4F90-8252-ECAB4E68BECAQ35117700-E613DD55-DDEF-423C-A58A-9D6B11739696Q35163137-969F0D7D-B3ED-40EB-9918-9CD58EA8535BQ35224446-DBAB78D0-E1B1-4B3A-8178-C2E6906EDB52Q35225575-885B543A-BB9D-4200-9CDF-B91224C40CDFQ35543421-61BABA37-DF6C-42B5-BA24-DF305415F73CQ35888079-87400472-9C9F-4BC5-B231-183F5AC57119Q36029384-A5F68DF6-E722-47E8-A410-CEA401713CB9Q36036041-541CF759-02AA-4C16-BF7E-F3121894DEF1Q36423444-2062BBB1-E757-423B-A9E1-C536767F1769Q36458435-54FF82F7-DB0D-4A1C-9C58-693AF658EDCDQ36515043-B794202A-4A00-4331-9693-319A6A83217BQ36827355-F66FD293-B3B4-41F6-AD83-0A3BBAB23064Q36948768-A637E6C6-FDC3-4606-A43C-777B5F339C9EQ36952686-4C4AEE64-5C4B-4561-ABE7-E4DC7F8E52F1Q37022748-50FAA462-9514-4312-85B7-3ED329E8A295Q37064114-14B344BC-9D07-4CE1-AA90-96FFB0E2A9EEQ37235631-DAB75162-778B-4F89-BB22-3F964E7BCFF0Q37239737-1DC84A71-0B3D-403D-BE28-5B5232FF65E6Q37262554-4F06049E-63E3-46D2-835B-70D93D902DDFQ37403183-3D81C179-B18C-4567-81DF-847ED6C4FF43Q37418807-3700FFE3-6524-4090-AF12-42057D6511C1Q37455337-8A29C385-7554-43A9-9B94-7835F67AE361Q37463910-432D8152-87EB-4C40-9B8B-303DCFF28B70Q37967043-3276C79D-C2E6-47EA-9CB4-DC223690533FQ37982645-CA18F3D8-1D2F-457D-8F40-46DA82DD8BB4Q38652820-9D4616B6-226B-4EDB-9E0F-4A19DC0E6DACQ39834166-B8D04677-A10E-40F0-9BA4-4BF30A29057CQ40192525-0ED75209-C7DA-498B-9D49-C78A0296A466
P2860
Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 December 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Central obesity, incident micr ...... tions and complications study.
@en
Central obesity, incident micr ...... tions and complications study.
@nl
type
label
Central obesity, incident micr ...... tions and complications study.
@en
Central obesity, incident micr ...... tions and complications study.
@nl
prefLabel
Central obesity, incident micr ...... tions and complications study.
@en
Central obesity, incident micr ...... tions and complications study.
@nl
P2093
P2860
P356
P1476
Central obesity, incident micr ...... tions and complications study.
@en
P2093
Bessie Young
Diabetes Control and Complicat ...... lications Study Research Group
Ian H de Boer
John D Brunzell
Joshua N Sampson
Michael W Steffes
Noel S Weiss
Patricia A Cleary
Shalamar D Sibley
P2860
P304
P356
10.1681/ASN.2006040394
P577
2006-12-06T00:00:00Z